Turkish watchdog seeks input in ongoing pharma sector inquiry
( August 10, 2026, 09:53 GMT | Official Statement) -- MLex Summary: The Turkish competition authority is analyzing the relationship between patent protection, intellectual property and competition law as part of its ongoing inquiry into the pharmaceutical sector. The preliminary report published Monday assesses potential and atypical competition breaches, exclusivity practices, public procurement, the exercise of IP rights and competition issues that could arise from the regulatory framework and proposes targeted improvements. Interested parties can submit comments. Statement follows. The report is attached in Turkish. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.